The primary goal of the Developmental Core of the Harvard University CFAR is to promote basic, clinical, behavioral and translational HIV/AIDS research activities at Harvard University. The Developmental Core provides the infrastructure through which short-term research proposals from individual and collaborating investigators are solicited, reviewed, and funded. The Developmental Core also promotes HIV research collaboration across Harvard University, and facilitates the development of new experimental approaches in high priority areas. Through funding of Scholar awards and prioritizing funding of investigators without prior R01-type funding, the Developmental Core fosters career development of junior HIV researchers. Dr. Johnson will serve as the Director of the Developmental Core, working in concert with the Associate Director, Dr. Shahin Lockman (HSPH, BWH) and the HU CFAR Administrative Staff.

Public Health Relevance

The overarching goal of the Developmental Core is to further the research priorities of the HU CFAR as outlined by the research agendas of the Scientific Programs by helping to develop and promote multidisciplinary research in the prevention, detection, and treatment of HIV/AIDS in areas of basic, clinical, epidemiological, behavioral, and translational research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI060354-07
Application #
8125037
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
7
Fiscal Year
2010
Total Cost
$745,625
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Murray, Eleanor J; Robins, James M; Seage 3rd, George R et al. (2018) Using Observational Data to Calibrate Simulation Models. Med Decis Making 38:212-224
Martin-Gayo, Enrique; Cole, Michael B; Kolb, Kellie E et al. (2018) A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers. Genome Biol 19:10
Achuthan, Vasudevan; Perreira, Jill M; Sowd, Gregory A et al. (2018) Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration. Cell Host Microbe 24:392-404.e8
Biello, Katie B; Mimiaga, Matthew J; Santostefano, Christopher M et al. (2018) MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication. AIDS Behav 22:1158-1164
Trifonova, Radiana T; Barteneva, Natasha S (2018) Quantitation of IRF3 Nuclear Translocation in Heterogeneous Cellular Populations from Cervical Tissue Using Imaging Flow Cytometry. Methods Mol Biol 1745:125-153
Malone, Jowanna; Syvertsen, Jennifer L; Johnson, Blake E et al. (2018) Negotiating sexual safety in the era of biomedical HIV prevention: relationship dynamics among male couples using pre-exposure prophylaxis. Cult Health Sex 20:658-672
Neilan, Anne M; Cohn, Jennifer E; Lemaire, Jean-Francois et al. (2018) HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing? Open Forum Infect Dis 5:ofy170
Abdallah, Amir; Chang, Jonathan L; O'Carroll, Cumara B et al. (2018) Validation of the Intracerebral Hemorrhage Score in Uganda. Stroke 49:3063-3066
Manickam, Cordelia; Nwanze, Chiadika; Ram, Daniel R et al. (2018) Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS 32:1571-1578
Subbaraman, Ramnath; de Mondesert, Laura; Musiimenta, Angella et al. (2018) Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health 3:e001018

Showing the most recent 10 out of 1030 publications